Skip to main content
Bloomberg Logo
Bloomberg

Articles by Bloomberg

Bloomberg

Meta Starts 8,000 Global Job Cuts in AI Efficiency Push

Meta is alerting thousands of employees that they're being laid off, part of a previously announced restructuring aimed at reducing costs while the company invests heavily in artificial intelligence. The company began notifying workers around the world Wednesday morning, starting with employees across Asia, who got the note at 4 a.m. Singapore time. US-based staff are also expected to receive word during their morning, according to an internal memo. Bloomberg's Tom Mackenzie reports.

Read more
Bloomberg

30-Year Real Yields Starting to Look Interesting, RBC Says

Rufaro Chiriseri, head of fixed income for UK and Europe at RBC Wealth Management, discusses the outlook for Treasuries as 30-year yields climbed to levels not seen since the global financial crisis. "We're actually happy to be sort of on the shorter end," Chiriseri tells Bloomberg Television. "But at the same time, it starts to look a lot more interesting with 30-year real yields at levels that we haven't seen since the GFC."

Read more
Bloomberg

Samsung Workers to Go Ahead With Strike

Talks between Samsung Electronics and its largest labor union broke down, raising the prospect of a workers' strike. A general work stoppage will go ahead on Thursday, labor leader Choi Seung-ho told reporters. The collapse in negotiations puts the global technology supply chain at risk because Samsung is the world's biggest supplier of the chips that go into devices from data center servers to smartphones and electric vehicles. Bloomberg's Yoolim Lee reports.

Read more
Bloomberg

China's Biotech Boom, AI Limits and Regulatory Edge

China's healthcare and biotechnology sector is expanding rapidly, driven by scale, speed and a more efficient drug approval regime. This segment examines how artificial intelligence is helping cut early drug design costs, while leaving much of the expensive clinical and manufacturing process unchanged. The discussion also looks at why China has become a global leader in clinical trials and biotech infrastructure, and how more realistic valuations are reshaping public markets in Hong Kong. Simone Song, Founding Partner of Ori Capital, joined David Ingles from the sidelines of Sohn Hong Kong Investment Leaders Conference on Insight with Haslinda Amin to share her outlook on the sector and its risks.

Read more